EHS
EHS

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study

This paper was originally published by Rishi J Desai, Ameet Sarpatwari, Sara Dejene, Nazleen F Khan, Joyce Lii, James R Rogers, Sarah K Dutcher, Saeid Raofi, Justin Bohn, John Connolly, Michael A Fischer, Aaron S Kesselheim, and Joshua J Gagne in BMJ 2018; 361 under…
The post Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study appeared first on DrugPatentWatch – Make Better Decisions.

The post Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study appeared first on Biotechblog.

Source link

EHS
Back to top button